Sabar Karimah Es
SEC Form 4 insider trading activity
Sabar Karimah Es has filed 2 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Apr 3, 2026.
On the most recent filing, Sabar Karimah Es is listed as Director at CAPRICOR THERAPEUTICS, INC. Inside the rolling window, Sabar Karimah Es reported no open-market purchases and 3 open-market sales totaling $3.8M in CAPR. The largest disclosed transaction in the window is a sale of 61,265 CAPR shares on Mar 31, 2026, worth $1.8M.
Companies traded
Other insiders at CAPR
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.8M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Sabar Karimah Es made?
Sabar Karimah Es has filed 2 SEC Form 4 filings (6 transaction rows) across 1 company since 2026.
Which companies does Sabar Karimah Es trade?
Sabar Karimah Es has filed SEC Form 4 disclosures for 1 company, including CAPR.
When was Sabar Karimah Es's most recent SEC Form 4 filing?
Sabar Karimah Es's most recent SEC Form 4 filing on Tracefour is dated Apr 3, 2026.
What is Sabar Karimah Es's total buy and sell value in the current window?
Inside the rolling retention window, Sabar Karimah Es bought $0 and sold $3.8M based on SEC Form 4 filings.
What was Sabar Karimah Es's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 61,265 CAPR shares on 2026-03-31, worth $1.8M, per SEC Form 4 filings.